Cover Image

Durvalumab after sequential chemoradiotherapy in stage III, unresectable NSCLC: the phase 2 PACIFIC-6 trial

On the basis of the findings of the phase 3 PACIFIC trial (NCT02125461), durvalumab is standard of care for patients with stage III, unresectable NSCLC and no disease progression after concurrent chemoradiotherapy (cCRT). Many patients are considered unsuitable for cCRT owing to concerns with tolera...

Full description

Saved in:
Bibliographic Details
Main Authors: Garassino, Marina (Author) , Mazieres, Julien (Author) , Reck, Martin (Author) , Chouaid, Christos (Author) , Bischoff, Helge (Author) , Reinmuth, Niels (Author) , Cove-Smith, Laura (Author) , Mansy, Talal (Author) , Cortinovis, Diego (Author) , Migliorino, Maria R. (Author) , Delmonte, Angelo (Author) , Sánchez, José Garcia (Author) , Chara Velarde, Luis Enrique (Author) , Bernabe, Reyes (Author) , Paz-Ares, Luis (Author) , Perez, Ignacio Diaz (Author) , Trunova, Nataliya (Author) , Foroutanpour, Kayhan (Author) , Faivre-Finn, Corinne (Author)
Format: Article (Journal)
Language:English
Published: 9 August 2022
In: Journal of thoracic oncology
Year: 2022, Volume: 17, Issue: 12, Pages: 1415-1427
ISSN:1556-1380
DOI:10.1016/j.jtho.2022.07.1148
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jtho.2022.07.1148
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1556086422015003
Get full text
Author Notes:Marina C. Garassino, MD, Julien Mazieres, MD, Martin Reck, MD, Christos Chouaid, MD, Helge Bischoff, MD, Niels Reinmuth, MD, Laura Cove-Smith, MBChB, Talal Mansy, MBBS, Diego Cortinovis, MD, Maria R. Migliorino, MD, Angelo Delmonte, MD, José Garcia Sánchez, MD, Luis Enrique Chara Velarde, MD, Reyes Bernabe, MD, Luis Paz-Ares, MD, Ignacio Diaz Perez, MD, Nataliya Trunova, MD, Kayhan Foroutanpour, PhD, Corinne Faivre-Finn, MD

MARC

LEADER 00000caa a2200000 c 4500
001 1837312001
003 DE-627
005 20231114082737.0
007 cr uuu---uuuuu
008 230224s2022 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jtho.2022.07.1148  |2 doi 
035 |a (DE-627)1837312001 
035 |a (DE-599)KXP1837312001 
035 |a (OCoLC)1389535478 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Garassino, Marina  |e VerfasserIn  |0 (DE-588)1220527238  |0 (DE-627)1737458330  |4 aut 
245 1 0 |a Durvalumab after sequential chemoradiotherapy in stage III, unresectable NSCLC  |b the phase 2 PACIFIC-6 trial  |c Marina C. Garassino, MD, Julien Mazieres, MD, Martin Reck, MD, Christos Chouaid, MD, Helge Bischoff, MD, Niels Reinmuth, MD, Laura Cove-Smith, MBChB, Talal Mansy, MBBS, Diego Cortinovis, MD, Maria R. Migliorino, MD, Angelo Delmonte, MD, José Garcia Sánchez, MD, Luis Enrique Chara Velarde, MD, Reyes Bernabe, MD, Luis Paz-Ares, MD, Ignacio Diaz Perez, MD, Nataliya Trunova, MD, Kayhan Foroutanpour, PhD, Corinne Faivre-Finn, MD 
264 1 |c 9 August 2022 
300 |b Diagramme 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 14.11.2023 
520 |a On the basis of the findings of the phase 3 PACIFIC trial (NCT02125461), durvalumab is standard of care for patients with stage III, unresectable NSCLC and no disease progression after concurrent chemoradiotherapy (cCRT). Many patients are considered unsuitable for cCRT owing to concerns with tolerability. The phase 2 PACIFIC-6 trial (NCT03693300) evaluates the safety and tolerability of durvalumab after sequential CRT (sCRT). 
650 4 |a Durvalumab 
650 4 |a Immunotherapy 
650 4 |a Locally advanced 
650 4 |a Non-small-cell lung cancer 
650 4 |a Sequential chemoradiotherapy 
700 1 |a Mazieres, Julien  |e VerfasserIn  |4 aut 
700 1 |a Reck, Martin  |e VerfasserIn  |4 aut 
700 1 |a Chouaid, Christos  |e VerfasserIn  |4 aut 
700 1 |a Bischoff, Helge  |d 1958-  |e VerfasserIn  |0 (DE-588)111184576  |0 (DE-627)389658286  |0 (DE-576)167287249  |4 aut 
700 1 |a Reinmuth, Niels  |e VerfasserIn  |4 aut 
700 1 |a Cove-Smith, Laura  |e VerfasserIn  |4 aut 
700 1 |a Mansy, Talal  |e VerfasserIn  |4 aut 
700 1 |a Cortinovis, Diego  |e VerfasserIn  |4 aut 
700 1 |a Migliorino, Maria R.  |e VerfasserIn  |4 aut 
700 1 |a Delmonte, Angelo  |e VerfasserIn  |4 aut 
700 1 |a Sánchez, José Garcia  |e VerfasserIn  |4 aut 
700 1 |a Chara Velarde, Luis Enrique  |e VerfasserIn  |4 aut 
700 1 |a Bernabe, Reyes  |e VerfasserIn  |4 aut 
700 1 |a Paz-Ares, Luis  |e VerfasserIn  |4 aut 
700 1 |a Perez, Ignacio Diaz  |e VerfasserIn  |4 aut 
700 1 |a Trunova, Nataliya  |e VerfasserIn  |4 aut 
700 1 |a Foroutanpour, Kayhan  |e VerfasserIn  |4 aut 
700 1 |a Faivre-Finn, Corinne  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of thoracic oncology  |d Amsterdam : Elsevier, 2006  |g 17(2022), 12 vom: Dez., Seite 1415-1427  |h Online-Ressource  |w (DE-627)508331986  |w (DE-600)2223437-8  |w (DE-576)336961553  |x 1556-1380  |7 nnas  |a Durvalumab after sequential chemoradiotherapy in stage III, unresectable NSCLC the phase 2 PACIFIC-6 trial 
773 1 8 |g volume:17  |g year:2022  |g number:12  |g month:12  |g pages:1415-1427  |g extent:13  |a Durvalumab after sequential chemoradiotherapy in stage III, unresectable NSCLC the phase 2 PACIFIC-6 trial 
856 4 0 |u https://doi.org/10.1016/j.jtho.2022.07.1148  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S1556086422015003  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230224 
993 |a Article 
994 |a 2022 
998 |g 111184576  |a Bischoff, Helge  |m 111184576:Bischoff, Helge  |d 910000  |d 950000  |d 950900  |e 910000PB111184576  |e 950000PB111184576  |e 950900PB111184576  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 5 
999 |a KXP-PPN1837312001  |e 4275612035 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1016/j.jtho.2022.07.1148"],"eki":["1837312001"]},"name":{"displayForm":["Marina C. Garassino, MD, Julien Mazieres, MD, Martin Reck, MD, Christos Chouaid, MD, Helge Bischoff, MD, Niels Reinmuth, MD, Laura Cove-Smith, MBChB, Talal Mansy, MBBS, Diego Cortinovis, MD, Maria R. Migliorino, MD, Angelo Delmonte, MD, José Garcia Sánchez, MD, Luis Enrique Chara Velarde, MD, Reyes Bernabe, MD, Luis Paz-Ares, MD, Ignacio Diaz Perez, MD, Nataliya Trunova, MD, Kayhan Foroutanpour, PhD, Corinne Faivre-Finn, MD"]},"recId":"1837312001","physDesc":[{"extent":"13 S.","noteIll":"Diagramme"}],"title":[{"subtitle":"the phase 2 PACIFIC-6 trial","title":"Durvalumab after sequential chemoradiotherapy in stage III, unresectable NSCLC","title_sort":"Durvalumab after sequential chemoradiotherapy in stage III, unresectable NSCLC"}],"note":["Gesehen am 14.11.2023"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"508331986","disp":"Durvalumab after sequential chemoradiotherapy in stage III, unresectable NSCLC the phase 2 PACIFIC-6 trialJournal of thoracic oncology","titleAlt":[{"title":"JTO"}],"pubHistory":["1.2006 -"],"origin":[{"publisher":"Elsevier ; Lippincott Williams & Wilkins","publisherPlace":"Amsterdam ; Philadelphia, Pa.","dateIssuedKey":"2006","dateIssuedDisp":"2006-"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"subtitle":"JTO ; official publication of the International Association for the Study of Lung Cancer","title":"Journal of thoracic oncology","title_sort":"Journal of thoracic oncology"}],"part":{"volume":"17","year":"2022","extent":"13","text":"17(2022), 12 vom: Dez., Seite 1415-1427","issue":"12","pages":"1415-1427"},"id":{"issn":["1556-1380"],"eki":["508331986"],"zdb":["2223437-8"]}}],"person":[{"family":"Garassino","given":"Marina","role":"aut","display":"Garassino, Marina"},{"role":"aut","given":"Julien","family":"Mazieres","display":"Mazieres, Julien"},{"display":"Reck, Martin","given":"Martin","role":"aut","family":"Reck"},{"display":"Chouaid, Christos","given":"Christos","role":"aut","family":"Chouaid"},{"family":"Bischoff","given":"Helge","role":"aut","display":"Bischoff, Helge"},{"display":"Reinmuth, Niels","given":"Niels","role":"aut","family":"Reinmuth"},{"family":"Cove-Smith","role":"aut","given":"Laura","display":"Cove-Smith, Laura"},{"family":"Mansy","given":"Talal","role":"aut","display":"Mansy, Talal"},{"display":"Cortinovis, Diego","role":"aut","given":"Diego","family":"Cortinovis"},{"display":"Migliorino, Maria R.","given":"Maria R.","role":"aut","family":"Migliorino"},{"family":"Delmonte","given":"Angelo","role":"aut","display":"Delmonte, Angelo"},{"family":"Sánchez","role":"aut","given":"José Garcia","display":"Sánchez, José Garcia"},{"role":"aut","given":"Luis Enrique","family":"Chara Velarde","display":"Chara Velarde, Luis Enrique"},{"family":"Bernabe","role":"aut","given":"Reyes","display":"Bernabe, Reyes"},{"display":"Paz-Ares, Luis","family":"Paz-Ares","given":"Luis","role":"aut"},{"display":"Perez, Ignacio Diaz","family":"Perez","role":"aut","given":"Ignacio Diaz"},{"display":"Trunova, Nataliya","family":"Trunova","given":"Nataliya","role":"aut"},{"display":"Foroutanpour, Kayhan","family":"Foroutanpour","given":"Kayhan","role":"aut"},{"display":"Faivre-Finn, Corinne","role":"aut","given":"Corinne","family":"Faivre-Finn"}],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"9 August 2022"}]} 
SRT |a GARASSINOMDURVALUMAB9202 

Similar Items